Blood Group Typing Market by Techniques (Assay-Based Techniques, Massively Parallel Sequencing, Microarray), Test Type (ABO Blood Tests, Antibody Screening, Antigen Typing), Product, End-User - Global Forecast 2024-2030

Blood Group Typing Market by Techniques (Assay-Based Techniques, Massively Parallel Sequencing, Microarray), Test Type (ABO Blood Tests, Antibody Screening, Antigen Typing), Product, End-User - Global Forecast 2024-2030

The Blood Group Typing Market size was estimated at USD 3.37 billion in 2023 and expected to reach USD 3.63 billion in 2024, at a CAGR 7.82% to reach USD 5.72 billion by 2030.

Blood group typing, also known as blood typing or blood classification, is a crucial process in transfusion medicine and transplantation. It involves identifying specific antigens, proteins, and carbohydrates on the surface of red blood cells (RBCs) and determining an individual's blood group. The increasing demand for safe blood transfusion practices worldwide is one of the primary factors contributing to the market growth. This demand arises due to a growing prevalence of chronic diseases that require frequent blood transfusions. However, high costs associated with advanced testing techniques, such as molecular assays, limit their adoption, particularly in low-resource settings. A lack of skilled professionals capable of operating advanced instruments is another critical challenge th industry faces. Additionally, government initiatives improve healthcare infrastructure, and increased investment from private organizations presents opportunities for market players. Adopting automation technologies, including Next-Generation Sequencing (NGS), can significantly enhance throughput capabilities while reducing human errors during testing.

Regional Insights

In the Americas, the U.S. and Canada significantly increased the adoption of blood group typing owing to its advanced healthcare infrastructure and huge demand for blood transfusions. Key players have recently invested in research initiatives such as the NIH-funded National Blood Donor Project. In Canada, a rise in government funding for healthcare organizations is driving demand for blood group typing technologies. The Asia-Pacific region is encountering substantial growth due to increased government spending on healthcare and advancements in medical technologies. In China, patent filings related to blood group typing have surged, indicating strong research and market potential. Japan's aging population and India's rising awareness of blood-related disorders drive the need for accurate and efficient blood typing solutions. In Europe, growing investments in biotechnology and life sciences fuel market growth. The EU's Horizon 2020 program has prioritized personalized medicine research through initiatives 'Towards Next-Generation ICTs for Health.' The Middle East and Africa region face unique challenges from their diverse populations and health disparities. However, an increasing focus on improving healthcare access creates opportunities for blood group typing providers.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Blood Group Typing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing cases of road accidents, emergencies, and trauma
• Rising adoption of blood group typing in forensic sciences
• Strict regulatory standards regarding blood transfusion

Market Restraints

• Lack of awareness and skilled professional

Market Opportunities

• Advancements and developments in the blood group typing systems
• Increasing R&D activities and product innovations in blood group typing

Market Challenges

• Risk associated with transmissible diseases

Market Segmentation Analysis

• Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
• Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
• Product: Significant use of consumables and instruments in blood group typing services
• End-User: Emerging use of blood group typing services in clinical laboratories and hospitals

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Group Typing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Group Typing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing

My Personal Health Bank and Eldon Biologicals A/S have joined forces to transform healthcare by incorporating blood typing technology into their platform. By integrating the Eldoncard, a reliable and user-friendly point-of-care blood typing card, users can securely store their blood type data in their personal health profiles within the platform. This collaboration offers a seamless experience, granting users convenient access to their blood type information in conjunction with other health records.

Metropolis Healthcare launches test for HSCT & solid organ transplantation

Metropolis Healthcare launched the NextGen HLA Typing Test, an advanced molecular test powered by Next Generation Sequencing (NGS). This innovative test plays a crucial role in identifying suitable donors for bone marrow, cord blood, or organ transplants by analyzing the Human Leukocyte Antigen (HLA) genes. By utilizing Metropolis' NextGen HLA Typing test, the chances of successful transplants are significantly increased, as it provides a higher percentage of HLA matches.

NHSBT Researchers Discover New Blood Group System

A team of investigators from NHSBT and the University of Bristol has made a significant discovery in the field of Blood Group Typing. They have identified a new rare blood group system called Er, which has proven instrumental in solving two cases of Hemolytic Disease of the Fetus and Newborn (HDFN). New tests have been developed to effectively identify individuals with uncommon blood groups, leading to improved patient care and treatment outcomes.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Group Typing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Techniques
• Assay-Based Techniques
• Massively Parallel Sequencing
• Microarray
• Test Type
• ABO Blood Tests
• Antibody Screening
• Antigen Typing
• Cross-Matching Series
• Human Leukocyte Antigen Typing
• Product
• Consumables
• Instruments
• Services
• End-User
• Blood Banks
• Clinical Laboratories
• Hospitals

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year